简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Elon Musk Says Neuralink Will Do 'Life-Changing' Good For Billions As Company Successfully Adds 9 BCI Implants, Targets 20 By End Of 2025

2025-07-22 14:57

Elon Musk has hailed Neuralink as the billionaire's Brain-Chip Interface company successfully conducted its latest implant trial, taking the total number of Neuralink implant recipients to 9 patients.

What Happened: The billionaire took to social media platform X to hail the feat accomplished by Neuralink on Monday as he quoted a post from the company. Musk said that the company will do "life(live)-changing good" for "billions of people" through its work on the BCI implants.

"Imagine your loved one being able to walk again or your parent with dementia being able to recognize their child again," Musk added in the post.

Neuralink had said in the original post that the company had successfully conducted trials on Patients 8 and 9, adding that this was the first time Neuralink had accomplished two surgeries in a single day. 

Neuralink's co-founder DJ SEO also took to X on Monday to share that the company has set a target of conducting over 20 BCI implant trials before the end of the year.

Why It Matters: The news comes as Neuralink secured over $650 million in Series E funding, with investors including the likes of Cathie Wood's ARK Invest, fetching a valuation of over $9 billion.

Musk had also said that Neuralink plans to conduct trials of its vision-restoring implant, Blindsight, which could help completely blind people see again, in the UAE by 2026.

However, Musk's company has also been on the receiving end of criticism from the deaf community following the billionaire's claims that Neuralink would help restore hearing.

Read Next:

  • Trump’s New ZEV Credit Regulations Aren’t ‘As Bad’ For Elon Musk, Says Piper Sandler: ‘Tesla Will Still Book Around $3 Billion…’

Photo courtesy: rafapress / Shutterstock.com

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。